{"cik":"0001880438","ticker":"ANTX","name":"AN2 Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":null,"last_filing_date":null,"url":"/sec/cik-0001880438","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[],"related_endpoints":{"profile":"/sec/ANTX/profile","timeline":"/sec/ANTX/timeline","peers":"/sec/ANTX/peers","insider_pulse":"/sec/ANTX/insider-pulse","insider_summary":"/sec/ANTX/insider-summary","insider_transactions":"/sec/ANTX/insider-transactions","form144":"/sec/ANTX/form144","holdings_as_filer":"/sec/ANTX/holdings","financial_facts":"/sec/ANTX/financial-facts","derivatives":"/sec/ANTX/derivatives","officers":"/sec/ANTX/officers","insider_network":"/sec/ANTX/insider-network","risk_flags":"/sec/ANTX/risk-flags","filings":"/sec/ANTX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=ANTX"}}